» Articles » PMID: 23546879

Site-specific O-glycosylation on the MUC2 Mucin Protein Inhibits Cleavage by the Porphyromonas Gingivalis Secreted Cysteine Protease (RgpB)

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 2013 Apr 3
PMID 23546879
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The colonic epithelial surface is protected by an inner mucus layer that the commensal microflora cannot penetrate. We previously demonstrated that Entamoeba histolytica secretes a protease capable of dissolving this layer that is required for parasite penetration. Here, we asked whether there are bacteria that can secrete similar proteases. We screened bacterial culture supernatants for such activity using recombinant fragments of the MUC2 mucin, the major structural component, and the only gel-forming mucin in the colonic mucus. MUC2 has two central heavily O-glycosylated mucin domains that are protease-resistant and has cysteine-rich N and C termini responsible for polymerization. Culture supernatants of Porphyromonas gingivalis, a bacterium that secretes proteases responsible for periodontitis, cleaved the MUC2 C-terminal region, whereas the N-terminal region was unaffected. The active enzyme was isolated and identified as Arg-gingipain B (RgpB). Two cleavage sites were localized to IR↓TT and NR↓QA. IR↓TT cleavage will disrupt the MUC2 polymers. Because this site has two potential O-glycosylation sites, we tested whether recombinant GalNAc-transferases (GalNAc-Ts) could glycosylate a synthetic peptide covering the IRTT sequence. Only GalNAc-T3 was able to glycosylate the second Thr in IRTT, rendering the sequence resistant to cleavage by RgpB. Furthermore, when GalNAc-T3 was expressed in CHO cells expressing the MUC2 C terminus, the second threonine was glycosylated, and the protein became resistant to RgpB cleavage. These findings suggest that bacteria can produce proteases capable of dissolving the inner protective mucus layer by specific cleavages in the MUC2 mucin and that this cleavage can be modulated by site-specific O-glycosylation.

Citing Articles

Periodontal bacteria influence systemic diseases through the gut microbiota.

Xi M, Ruan Q, Zhong S, Li J, Qi W, Xie C Front Cell Infect Microbiol. 2024; 14:1478362.

PMID: 39619660 PMC: 11604649. DOI: 10.3389/fcimb.2024.1478362.


Cultivating complexity: Advancements in establishing in vitro models for the mucus-adhering gut microbiota.

Calvigioni M, Mazzantini D, Celandroni F, Vozzi G, Ghelardi E Microb Biotechnol. 2024; 17(10):e70036.

PMID: 39435730 PMC: 11494453. DOI: 10.1111/1751-7915.70036.


Bivalent chromatin accommodates survivin and BRG1/SWI complex to activate DNA damage response in CD4 cells.

Chandrasekaran V, Andersson K, Erlandsson M, Li S, Olsson T, Garcia-Bonete M Cell Commun Signal. 2024; 22(1):440.

PMID: 39261837 PMC: 11389452. DOI: 10.1186/s12964-024-01814-4.


The oral-gut microbiome axis in health and disease.

Kunath B, De Rudder C, Laczny C, Letellier E, Wilmes P Nat Rev Microbiol. 2024; 22(12):791-805.

PMID: 39039286 DOI: 10.1038/s41579-024-01075-5.


Bacteriophage defends murine gut from Escherichia coli invasion via mucosal adherence.

Wu J, Fu K, Hou C, Wang Y, Ji C, Xue F Nat Commun. 2024; 15(1):4764.

PMID: 38834561 PMC: 11150434. DOI: 10.1038/s41467-024-48560-2.


References
1.
Pike R, McGraw W, Potempa J, Travis J . Lysine- and arginine-specific proteinases from Porphyromonas gingivalis. Isolation, characterization, and evidence for the existence of complexes with hemagglutinins. J Biol Chem. 1994; 269(1):406-11. View

2.
Lu A, Wisniewski J, Mann M . Comparative proteomic profiling of membrane proteins in rat cerebellum, spinal cord, and sciatic nerve. J Proteome Res. 2009; 8(5):2418-25. DOI: 10.1021/pr8010364. View

3.
Lidell M, Johansson M, Morgelin M, Asker N, Gum Jr J, Kim Y . The recombinant C-terminus of the human MUC2 mucin forms dimers in Chinese-hamster ovary cells and heterodimers with full-length MUC2 in LS 174T cells. Biochem J. 2003; 372(Pt 2):335-45. PMC: 1223394. DOI: 10.1042/BJ20030003. View

4.
Bennett E, Mandel U, Clausen H, Gerken T, Fritz T, Tabak L . Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2011; 22(6):736-56. PMC: 3409716. DOI: 10.1093/glycob/cwr182. View

5.
Mandel U, Hassan H, Therkildsen M, Rygaard J, Jakobsen M, Juhl B . Expression of polypeptide GalNAc-transferases in stratified epithelia and squamous cell carcinomas: immunohistological evaluation using monoclonal antibodies to three members of the GalNAc-transferase family. Glycobiology. 1999; 9(1):43-52. DOI: 10.1093/glycob/9.1.43. View